What Jim Cramer Thinks About Abbott Laboratories Post-Earnings

What's going on with Abbott? And what does Jim Cramer think about the stock?

The company earned an adjusted $1.32 a share, double the 65 cents a share of the year-earlier quarter. Revenue rose 35% to $10.46 billion.

All four of Abbott's major businesses ["achieved] strong growth," said CEO Robert B. Ford in a statement.  "We're particularly pleased with the growing momentum of several recently launched products and continue to forecast more than 35% earnings-per-share growth for the year."

Recap TheStreet Live: Everything Jim Cramer Is Watching Tuesday